The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy via Enhancing Innate Immunity
Abstract
Abstract Cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) are essential components of the innate immune sensors to cytosolic DNA and elicit type I interferon (IFN). Recent studies have revealed that manganese (Mn) can enhance cGAS and STING activation to viral infection. However, the role of Mn in antitumor immunity has not been explored. Here, we designed a nanoactivator, which can induce the presence of DNA in cytoplasm and simultaneously elevate Mn2+ accumulation within tumor cells. In detail, amorphous porous manganese phosphate (APMP) NPs that are highly responsive to tumor microenvironment were employed to construct doxorubicin (DOX)-loaded and phospholipid (PL)-coated hybrid nanoparticles (PL/APMP-DOX NPs). PL/APMP-DOX NPs were stably maintained during systemic circulation, but triggered to release DOX for inducing DNA damage and Mn2+ to augment cGAS/STING activity. We found that PL/APMP-DOX NPs with superior tumor-targeting capacity boosted dendritic cell maturation and increased cytotoxic T lymphocyte infiltration as well as natural killer cell recruitment into the tumor site. Furthermore, the NPs increased production of type I IFN and secretion of pro-inflammatory cytokines (for example, TNF-α and IL-6). Consequently, PL/APMP-DOX NPs exhibited excellent antitumor efficacy and prolonged the lifespan of the tumor-bearing mice. Collectively, we developed a PL-decorated Mn-based hybrid nanoactivator to intensify immune activation and that might provide therapeutic potential for caner immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Woo, S.-R., Fuertes, M. B., Corrales, L., Spranger, S., Furdyna, M. J., Leung, M. Y. K., Duggan, R., Wang, Y., Barber, G. N., Fitzgerald, K. A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.017 · Cited by 1,917
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Vanpouille-Box, C., Alard, A., Aryankalayil, M. J., Sarfraz, Y., Diamond, J. M., Schneider, R. J., Inghirami, G., Coleman, C. N., Formenti, S. C., & Demaria, S. (2017) · Nature Communications · doi:10.1038/ncomms15618 · Cited by 1,834
Yang, G., Xu, L., Chao, Y., Xu, J., Sun, X., Wu, Y., Peng, R., & Liu, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-01050-0 · Cited by 1,477
Cytoplasmic chromatin triggers inflammation in senescence and cancer
Dou, Z., Ghosh, K., Vizioli, M. G., Zhu, J., Sen, P., Wangensteen, K. J., Simithy, J., Lan, Y., Lin, Y., Zhou, Z., et al. (2017) · Nature · doi:10.1038/nature24050 · Cited by 1,335
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Wang, C., Guan, Y., Lv, M., Zhang, R., Guo, Z., Wei, X., Du, X., Yang, J., Li, T., Wan, Y., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.017 · Cited by 869
Nuclear cGAS suppresses DNA repair and promotes tumorigenesis
Liu, H., Zhang, H., Wu, X., Ma, D., Wu, J., Wang, L., Jiang, Y., Fei, Y., Zhu, C., Tan, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0629-6 · Cited by 650
Self-citationTransformable liquid-metal nanomedicine
Lu, Y., Hu, Q., Lin, Y., Pacardo, D. B., Wang, C., Sun, W., Ligler, F. S., Dickey, M. D., & Gu, Z. (2015) · Nature Communications · doi:10.1038/ncomms10066 · Cited by 593
Signalling strength determines proapoptotic functions of STING
Gulen, M. F., Koch, U., Haag, S. M., Schuler, F., Apetoh, L., Villunger, A., Radtke, F., & Ablasser, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00573-w · Cited by 505
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
Sivick, K. E., Desbien, A. L., Glickman, L. H., Reiner, G. L., Corrales, L., Surh, N. H., Hudson, T. E., Vu, U. T., Francica, B. J., Banda, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.047 · Cited by 451
STING directly activates autophagy to tune the innate immune response
Liu, D., Wu, H., Wang, C., Li, Y., Tian, H., Siraj, S., Sehgal, S. A., Wang, X., Wang, J., Shang, Y., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0251-z · Cited by 423
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Li, A., Yi, M., Qin, S., Song, Y., Chu, Q., & Wu, K. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0721-x · Cited by 413
Srikanth, S., Woo, J. S., Wu, B., El-Sherbiny, Y. M., Leung, J., Chupradit, K., Rice, L., Seo, G. J., Calmettes, G., Ramakrishna, C., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0287-8 · Cited by 374
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness
Scott, S. A., Selvy, P. E., Buck, J. R., Cho, H. P., Criswell, T. L., Thomas, A. L., Armstrong, M. D., Arteaga, C. L., Lindsley, C. W., & Brown, H. A. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.140 · Cited by 280
The STING pathway and the T cell-inflamed tumor microenvironment
Woo, S.-R., Corrales, L., & Gajewski, T. F. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.003 · Cited by 271
Durfee, P. N., Lin, Y.-S., Dunphy, D. R., Muñiz, A. J., Butler, K. S., Humphrey, K. R., Lokke, A. J., Agola, J. O., Chou, S. S., Chen, I.-M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02819 · Cited by 219
Huang, P., Chen, Y., Lin, H., Yu, L., Zhang, L., Wang, L., Zhu, Y., & Shi, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.018 · Cited by 215
Self-citationLiu, Q., Chen, F., Hou, L., Shen, L., Zhang, X., Wang, D., & Huang, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b01890 · Cited by 183
Self-citationCurrent challenges for cancer vaccine adjuvant development
Bowen, W. S., Svrivastava, A. K., Batra, L., Barsoumian, H., & Shirwan, H. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1434000 · Cited by 160
Deng, C., Zhang, Q., Jia, M., Zhao, J., Sun, X., Gong, T., & Zhang, Z. (2019) · Advanced Science · doi:10.1002/advs.201801868 · Cited by 158
Self-citationCell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling
Zhang, Y., Tang, K., Zhang, Y., Ma, R., Ma, J., Li, Y., Luo, S., Liang, X., Ji, T., Gu, Z., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0177 · Cited by 152
Henkels, K. M., Boivin, G. P., Dudley, E. S., Berberich, S. J., & Gómez-Cambronero, J. (2013) · Oncogene · doi:10.1038/onc.2013.207 · Cited by 135
Zhang, C.-X., Ye, S., Ni, J., Cai, T., Liu, Y.-N., Huang, D.-J., Mai, H., Chen, Q.-Y., He, J., Zhang, X.-S., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0302-0 · Cited by 135
Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease
Nelson, R. K., & Frohman, M. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r059220 · Cited by 128
Li, T., Li, K., Zhang, Q., Wang, C., Yue, Y., Chen, Z., Yuan, S.-J., Liu, X., Wen, Y., Han, M. H., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.035 · Cited by 127
Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies
Iurescia, S., Fioretti, D. P., & Rinaldi, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00711 · Cited by 124
Trial watch: Chemotherapy with immunogenic cell death inducers
Vacchelli, E., Galluzzi, L., Fridman, W. H., Galon, J., Sautès‐Fridman, C., Tartour, É., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.1.2.19026 · Cited by 124
Ultra-small lipid–polymer hybrid nanoparticles for tumor-penetrating drug delivery
Dehaini, D., Fang, R. H., Luk, B. T., Pang, Z., Hu, C. J., Kroll, A. V., Yu, C. L., Gao, W., & Zhang, L. (2016) · Nanoscale · doi:10.1039/c6nr04091h · Cited by 109
Self-citationLewis, J. A., Scott, S. A., Lavieri, R. R., Buck, J. R., Selvy, P. E., Stoops, S. L., Armstrong, M. D., Brown, H. A., & Lindsley, C. W. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.057 · Cited by 102
An, M., Yu, C., Xi, J., Reyes, J. D., Mao, G., Wei, W., & Liu, H. (2018) · Nanoscale · doi:10.1039/c8nr01376d · Cited by 97
Watkins-Schulz, R., Tiet, P., Gallovic, M. D., Junkins, R. D., Batty, C. J., Bachelder, E. M., Ainslie, K. M., & Ting, J. P. ‐. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.03.011 · Cited by 93
Hou, L., Liu, Q., Shen, L., Liu, Y., Zhang, X., Chen, F., & Huang, L. (2018) · Theranostics · doi:10.7150/thno.24821 · Cited by 91
Self-citationLiu, Q., Zhu, H., Tiruthani, K., Shen, L., Chen, F., Gao, K., Zhang, X., Hou, L., Wang, D., Liu, R., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07384 · Cited by 83
Self-citationJi, T., Lang, J., Ning, B., Qi, F., Wang, H., Zhang, Y., Zhao, R., Yang, X. P., Zhang, L., Li, W., et al. (2018) · Advanced Materials · doi:10.1002/adma.201804395 · Cited by 81
Self-citationSTING Signaling in Cancer Cells: Important or Not?
Sokołowska, O., & Nowis, D. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0481-7 · Cited by 79
cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response
Bose, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112456 · Cited by 70
STING signaling in tumorigenesis and cancer therapy: A friend or foe?
He, L., Xiao, X., Yang, X., Zhang, Z., Wu, L., & Liu, Z. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.026 · Cited by 64
Self-citationSong, R., Zhang, M., Liu, Y., Cui, Z., Zhang, H., Tang, Z., Chen, X., Wu, H., Yao, Z., He, M., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.018 · Cited by 55
Self-citationHao, Y., Zheng, C., Wang, L., Zhang, J., Niu, X., Song, Q., Feng, Q., Zhao, H., Li, L., Zhang, H., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.08.028 · Cited by 48
Self-citationBiosafe Nanoscale Pharmaceutical Adjuvant Materials
Jin, S., Li, S., Wang, C., Liu, J., Yang, X., Wang, P. C., Zhang, X., & Liang, X. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1898 · Cited by 35
Burin, Á. M., Fernandes, N. L. M., Snak, A., Fireman, A. K., Horn, D., & Fernandes, J. I. M. (2018) · Poultry Science · doi:10.3382/ps/pey570 · Cited by 29
Nanoporous Silica-Based Protocells at Multiple Scales for Designs of Life and Nanomedicine
Sun, J., Jakobsson, E., Wang, Y., & Brinker, C. J. (2015) · Life · doi:10.3390/life5010214 · Cited by 21
Kumar, S., Linehan, B., & Tseng, Y. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.042 · Cited by 8
Cited by
Lv, M., Chen, M., Zhang, R., Zhang, W., Wang, C., Zhang, Y., Wei, X., Guan, Y., Liu, J., Feng, K., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00395-4 · Cited by 1,040
Sun, X., Zhang, Y., Li, J., Park, K. S., Han, K., Zhou, X., Xu, Y., Nam, J., Xu, J., Shi, X., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00962-9 · Cited by 788
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 357
Jiang, M., Jia, K., Wang, L., Li, W., Chen, B., Liu, Y., Wang, H., Zhao, S., He, Y., & Zhou, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.003 · Cited by 320
Manganese‐Based Tumor Immunotherapy
Zhang, K., Qi, C., & Cai, K. (2023) · Advanced Materials · doi:10.1002/adma.202205409 · Cited by 288
Metadata
- Authors
- Hou, L., Tian, C., Yan, Y., Zhang, L., Zhang, H., & Zhang, Z.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-04-16
- Volume
- 14
- Issue
- 4
- Pages
- 3927-3940
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3017215961
- Cited by
- 309
- References
- 47
- FWCI
- 12.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.